Citation: | CAO Lan, LI Kui-biao, CHEN Yi-yun, WU Di, ZENG Qing, XIA Dan, LIU Yan-hui, DI Biao, ZHANG Zhou-bin. Continuous monitoring of evolution and variation of influenza A (H1N1) viruses in Guangzhou, 2017-2019[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2021, 25(3): 359-362. doi: 10.16462/j.cnki.zhjbkz.2021.03.020 |
[1] |
陈国平, 李芙蓉, 刘红, 等. 甲型H1N1流感大流行的流行病学概述[J]. 中华疾病控制杂志, 2011, 15(7): 619-621. http://zhjbkz.ahmu.edu.cn/article/id/JBKZ201107020
Chen GP, Li FR, Liu H, et al. An outline of epidemiologic features of influenza A(H1N1) pandemic[J]. Chin J Dis Control Prev, 2011, 15(7): 619-621. http://zhjbkz.ahmu.edu.cn/article/id/JBKZ201107020
|
[2] |
曹蓝, 李魁彪, 马钰, 等. 2017年广州市流感暴发疫情病原学监测与分析[J]. 热带医学, 2018, 18(12): 1619-1622. doi: 10.3969/j.issn.1672-3619.2018.12.019
Cao L, Li KB, Ma Y, et al. Pathogenic monitoring and analysis of influenza outbreak in Guangzhou, 2017[J]. J Trop Med, 2018, 18(12): 1619-1622. doi: 10.3969/j.issn.1672-3619.2018.12.019
|
[3] |
Liu SS, Jiao XY, Wang S, et al. Susceptibility of influenza A (H1N1) /pdm2009, seasonal A (H3N2) and B viruses to Oseltamivir in Guangdong, China between 2009 and 2014[J]. Sci Rep, 2017, 7(1): 8488. DOI: 10.1038/s41598-017-08282-6.
|
[4] |
陈艺韵, 鲁恩洁, 曹蓝, 等. 广州市2012-2016年A型季节性流感的流行特征分析[J]. 中国热带医学, 2017, 17(11): 1098-1101. DOI: 10.13604/j.cnki.46-1064/r.2017.11.09.
Chen YY, Lu EJ, Cao L, et al. Epidemiological characteristics of seasonal influenza A in Guangzhou, 2012-2016[J]. China Tropical Medicine, 2017, 17(11): 1098-1101. DOI: 10.13604/j.cnki.46-1064/r.2017.11.09.
|
[5] |
鲁恩洁, 陈艺韵, 陈宗遒, 等. 广州市2017-2018年流感疫情病原学监测结果分析[J]. 国际病毒学杂志, 2020, 27(2): 124-127. DOI: 10.3760/cma.j.issn.1673-4092.2020.02.008.
Lu EJ, Chen YY, Chen ZQ, et al. Surveillance of influenza outbreaks in Guangzhou, 2017-2018[J]. Int J Virol, 2020, 27(2): 124-127. DOI: 10.3760/cma.j.issn.1673-4092.2020.02.008.
|
[6] |
吴春利, 阳帆, 黄达娜, 等. 2009-2014年深圳市甲型H1N1流感病毒系统进化及分子变异研究[J]. 国际病毒学杂志, 2015, 22(6): 389-393. DOI: 10.3760/cma.j.issn.1673 4092.2015.06.008.
Wu CL, Yang F, Huang DN, et al. Phyletic evolution and molecular variation of pandemic influenza A(H1N1) 2009 virus in Shenzhen from 2009 to 2014[J]. Int J Virol, 2015, 22(6): 389-393. DOI: 10.3760/cma.j.issn.1673 4092.2015.06.008.
|
[7] |
许晶, 史伟, 张蕾, 等. 2017-2018年度陕西省甲型H1N1流感病毒基因特征分析[J]. 现代预防医学, 2019, 46(20): 3782-3786. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYF201920031.htm
Xu J, Shi W, Zhang L, et al. Genetic characterization of influenza A (H1N1) virus in Shaanxi in 2017-2018[J]. Modern Preventive Medicine, 2019, 46(20): 3782-3786. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYF201920031.htm
|
[8] |
黄一伟, 张斯钰, 湛志飞, 等. 2009-2018年湖南省甲型H1N1亚型流感病毒监测结果及其全基因组进化分析[J]. 疾病监测, 2019, 34(10): 885-890. DOI: 10.3784/j.issn.1003-9961.2019.10.006.
Huang YW, Zhang SY, Zhan ZF, et al. Sentinel surveillance and whole genome evolution of influenza A (H1N1) pdm09 in Hunan, 2009-2018[J]. Disease Surveillance, 2019, 34(10): 885-890. DOI: 10.3784/j.issn.1003-9961.2019.10.006.
|
[9] |
方斌, 刘琳琳, 李翔, 等. 湖北省大流行期和流行后期新甲型H1N1流感病毒基因特性分析[J]. 中华疾病控制杂志, 2017, 21(1): 13-18. DOI: 10.16462 /j.cnki.zhjbkz.2017.01.003.
Fang B, Liu LL, Li X, et al. Evolutionary feature analysis of influenza A (H1N1pdm09) viruses in Hubei during the pandemic and post-pandemic periods[J]. Chin J Dis Control Prev, 2017, 21(1): 13-18. DOI: 10.16462 /j.cnki.zhjbkz.2017.01.003.
|
[10] |
Xu R, Ekiert DC, Krause JC, et al. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus[J]. Science, 2010, 328(5976): 357-360. DOI: 10.1126/science.1186430.
|
[11] |
Li L, Liu Y, Wu P, et al. Influenza-associated excess respiratory mortality in China, 2010-15: a population-based study[J]. Lancet Public Health, 2019, 4(9): e473-e481. DOI: 10.1016/S2468-2667(19)30163-X.
|
[12] |
李铁钢, 王鸣. 在抗击新型冠状病毒肺炎疫情同时警惕季节性流感的叠加效应[J]. 中华预防医学杂志, 2020, 54(4): 337-339. DOI: 10.3760/cma.j.cn11250-20200208-00078.
Li TG, Wang M. Be alert to superposed effect of seasonal influenza while fighting against COVID-19[J]. Chin J Prev Med, 2020, 54(4): 337-339. DOI: 10.3760/cma.j.cn11250-20200208-00078.
|
[13] |
Bai L, Zhao Y, Dong J, et al. Coinfection with influenza A virus enhances SARS-CoV-2 infectivity[J]. Cell Res, 2021, 1-9. DOI: 10.1038/s41422-021-00473-1.
|